Weinberg's Pharma Omnium sells Biodim subsidiary
France-based Pharma Omnium International, a portfolio company of Weinberg Capital Partners (WCP), has sold its subsidiary Laboratoire Biodim to pharmaceutical business NuPharm, backed by Apax Partners.
More on Exits
HIG exits Royo Group's furniture unit
HIG, alongside the Royo family, retains Royo's shower tray business, which operates under the Fiora brand
EMH sells stake in Native Instruments
SBO to Francisco Partners sees EMH and Native Instruments' management retain a minority stake
InfraVia's Celeste acquires PE-backed VTX Telecom
Exiting their stakes, Iris and Siparex first invested in the telecoms service in 1999 and 2005 respectively
Baird sells Prescient to BDC
In November 2020, the vendor requested another set of indicative offers from seven or eight bidders
Latest News
LP Profile: IMCO
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Elbrus holds first close on $260m for third fund – report
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018